Morgans just upgraded these ASX shares to buys

Morgans has just upgraded these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for some new additions to your portfolio in March, then you may want to check out the shares listed below.

These ASX shares have recently been upgraded to buy ratings by the team at Morgans. Here's what the broker is saying about them:

Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

Cochlear Limited (ASX: COH)

Morgans is positive on this hearings solutions specialist and upgraded its shares to an add rating with a $233.20 price target last week.

Its analysts were impressed with Cochlear's half year results, which came in ahead of expectations thanks to strong sales growth and expanding margins. Looking ahead, the broker believes the company's earnings profile is improving, potentially making it a good time to invest.

Morgans explained: "While we continue to believe a full recovery from COVID-based disruptions still has time to play out, improving demand and strong pipeline, coupled with management's increasing confidence, is all suggestive of an improving earnings profile."

Super Retail Group Ltd (ASX: SUL)

This retail conglomerate could be in the buy zone according to Morgans. Last week the broker upgraded its shares to an add rating with a $13.80 price target.

The broker notes that its shares have been sold off following its results and feels this has created a buying opportunity for investors.

Morgans commented: "Adjusting for the timing of Boxing Day, SUL's 1H22 EBIT was 3% above our forecast. Sales were considerably better than expected, with BCF, Supercheap Auto and rebel all delivering double-digit LFLs on a two-year stack. There are no major changes to our full year EBIT estimates. We upgrade our rating from HOLD to ADD as today's share price decline has put the stock on an FY23F P/E of 12.3x and EV/EBIT of 10.3x, which we see as too low for the quality of the business."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Cochlear Ltd. and Super Retail Group Limited. The Motley Fool Australia owns and has recommended Super Retail Group Limited. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »